Review highlights recent transformations in drug target prioritization and gene regulation linking GWAS findings to biology.
With a vast corpus of findings from nearly two decades of genome-wide association studies (GWASs), many studies now focus on translating these genetic associations into biological insights at multiple scales, from proteins and cells to entire organs. This approach will help build the foundation for the next generation of treatments. In this review, we highlight key recent studies that have informed target prioritization and drug repurposing, linked genetic variants to gene regulation in cellular contexts, and uncovered the genetic architecture of organ structure and function. Nearly 25 years after the initial draft of the human genome, it is clear that genomics is driving tangible advances in therapies and opening new ways to understand multi-scale biology.
No takes yet. Share an insight, caveat, or question.
Felici et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: